MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
$8,829,000
EPS
$0.18
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Unrealized gain on investments
-
-
0
0
Foreign currency translation adjustment
-
-339,000
-7,000
-176,000
Other comprehensive income (gain)
-
-
-7,000
-176,000
Revenue
153,604,000
141,249,000
140,500,000
134,269,000
Cost of revenue
34,975,000
31,938,000
35,163,000
32,937,000
Gross profit
118,629,000
109,311,000
105,337,000
101,332,000
Research and development expenses
26,402,000
24,235,000
24,505,000
22,892,000
Selling, general and administrative expenses
82,562,000
84,550,000
78,341,000
78,232,000
Total operating expenses
108,964,000
108,785,000
102,846,000
101,124,000
Income (gain) from operations
9,665,000
526,000
2,491,000
208,000
Interest expense
1,318,000
1,340,000
1,504,000
1,468,000
Interest income
1,179,000
1,245,000
1,331,000
1,165,000
Loss on debt extinguishment
-
-
0
0
Other income (expense)
-100,000
-37,000
42,000
9,000
Income (gain) before income tax expense
9,426,000
394,000
2,360,000
-86,000
Income tax expense
471,000
286,000
604,000
181,000
Net income (gain)
8,955,000
108,000
1,756,000
-267,000
Foreign currency translation adjustment
-126,000
-
-
-
Comprehensive income (gain), net of tax
8,829,000
-231,000
1,749,000
-443,000
Basic EPS
0.18
0
0.036
-0.01
Diluted EPS
0.18
0
0.036
-0.01
Basic Average Shares
48,667,000
48,334,000
47,966,000
47,920,000
Diluted Average Shares
48,868,000
49,046,000
47,966,000
47,920,000
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
Appendage Management
$51,614,000
(14.42%↑ Y/Y)
Openheart
$40,885,000
(12.11%↑ Y/Y)
Pain Management
$27,058,000
(27.83%↑ Y/Y)
Minimally Invasive
$6,031,000
(-23.06%↓ Y/Y)
Appendage Management
$12,373,000
(14.54%↑ Y/Y)
Openheart
$11,243,000
(8.64%↑ Y/Y)
Pain Management
$2,380,000
(17.07%↑ Y/Y)
Minimally Invasive
$2,020,000
(-14.84%↓ Y/Y)
US
$125,588,000
(13.57%↑ Y/Y)
Non Us
$28,016,000
(9.63%↑ Y/Y)
Revenue
$153,604,000
(12.83%↑ Y/Y)
Gross profit
$118,629,000
(16.90%↑ Y/Y)
Cost of revenue
$34,975,000
(0.92%↑ Y/Y)
Income (gain) from
operations
$9,665,000
(256.09%↑ Y/Y)
Interest income
$1,179,000
(25.29%↑ Y/Y)
Total operating
expenses
$108,964,000
(1.20%↑ Y/Y)
Income (gain) before
income tax expense
$9,426,000
(258.98%↑ Y/Y)
Interest expense
$1,318,000
(-11.54%↓ Y/Y)
Other income
(expense)
-$100,000
(-112.32%↓ Y/Y)
Selling, general and
administrative expenses
$82,562,000
(5.32%↑ Y/Y)
Research and development
expenses
$26,402,000
(-9.84%↓ Y/Y)
Net income (gain)
$8,955,000
(244.67%↑ Y/Y)
Income tax expense
$471,000
(80.46%↑ Y/Y)
Comprehensive income (gain),
net of tax
$8,829,000
(269.43%↑ Y/Y)
Foreign currency
translation adjustment
-$126,000
(-112.87%↓ Y/Y)
Buy us a coffee
AtriCure, Inc. (ATRC)
AtriCure, Inc. (ATRC)